Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Enhanced Expression and Activity of DNA Polymerase β in Chronic Myelogenous Leukemia

YVAN CANITROT, GUY LAURENT, CATHERINE ASTARIE-DEQUEKER, CHRISTINE BORDIER, CHRISTOPHE CAZAUX and JEAN-SÉBASTIEN HOFFMANN
Anticancer Research January 2006, 26 (1B) 523-525;
YVAN CANITROT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: canitrot{at}ipbs.fr
GUY LAURENT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CATHERINE ASTARIE-DEQUEKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTINE BORDIER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTOPHE CAZAUX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEAN-SÉBASTIEN HOFFMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Chronic myelogenous leukemia (CML) is characterized by an initial chronic phase that invariably evolves to the more aggressive phase of blast crisis. Although the determinants of this transition are still unknown, it has been shown that the blast crisis is accompanied by genetic instability. Materials and Methods: The expression and activity of the error-prone DNA polymerase beta (pol β) were investigated in blood samples from CML patients, by Western blotting and by an in vitro replication assay, respectively. Results: Pol β expression and activity were significantly higher in CML samples compared to those of healthy donors. Conclusion: Our results suggest that the excess of pol β in CML could contribute to the genetic instability observed during the evolution of the disease from the chronic phase to blast crisis.

  • DNA polymerase β
  • BCR-ABL
  • chronic myelogenous leukemia
  • genetic instability

Footnotes

  • Received August 12, 2005.
  • Revision received October 25, 2005.
  • Accepted November 14, 2005.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 1B
January-February 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Enhanced Expression and Activity of DNA Polymerase β in Chronic Myelogenous Leukemia
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Enhanced Expression and Activity of DNA Polymerase β in Chronic Myelogenous Leukemia
YVAN CANITROT, GUY LAURENT, CATHERINE ASTARIE-DEQUEKER, CHRISTINE BORDIER, CHRISTOPHE CAZAUX, JEAN-SÉBASTIEN HOFFMANN
Anticancer Research Jan 2006, 26 (1B) 523-525;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Enhanced Expression and Activity of DNA Polymerase β in Chronic Myelogenous Leukemia
YVAN CANITROT, GUY LAURENT, CATHERINE ASTARIE-DEQUEKER, CHRISTINE BORDIER, CHRISTOPHE CAZAUX, JEAN-SÉBASTIEN HOFFMANN
Anticancer Research Jan 2006, 26 (1B) 523-525;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Regulation of DNA Polymerase {beta} by the LMP1 Oncoprotein of EBV through the Nuclear Factor-{kappa}B Pathway
  • Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice
  • Google Scholar

More in this TOC Section

  • Evaluation of the Validity of Pancreatoduodenectomy for Elderly Patients With Ampullary Carcinoma from the Perspective of Nutritional Status at Recurrence
  • Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy
  • Expression of Vascular Endothelial Growth Factor A in Gallbladder Cancer Cells: A Clinicopathological Study
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire